Home » Newsletters » BioWorld Asia

BioWorld Asia

June 3, 1998

View Archived Issues

Canadian Start-Ups Increase With Surge In Venture Capital

Exiqon Spins Off Firm For Drugs That Mimic Nucleic Acids

Australia Earmarking A$20M To Boost Biotech Industry

EU Renews Efforts To Adopt Orphan Drug Regulations

Karo Bio Extends Alliance With UC Collaborators

Former Pharma Execs Bringing European Biotech To Japan

Progen Shares Surge, Retreat As Cancer Drug Enters Phase I

Inex Mouse Data Promising On Cancer Gene Therapy

Interferon Gene Therapy Beats HIV In Lab Studies

EU Explains 'Exceptional' Approval For Ares' Rebif

Other News to Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
K2 nabs two Antengene bispecific TCEs in $2B license, option deal
BioWorld
MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...